Fortnight 11: 17 May to 30 May 2014

The Communicable Diseases Network Australia holds fortnightly teleconferences to share and evaluate the latest information and developments in communicable diseases surveillance. This report provides a fortnightly summary on diseases of current interest and notifications of Australia's nationally notifiable diseases.

Page last updated: 05 June 2014

Fortnight 11: 17 May to 30 May 2014

If you are unable to download any of the above files please email OHP Webmaster.

Influenza (laboratory confirmed)

In this reporting period there were 582 confirmed influenza notifications with the majority continuing to be type A (78%). Type B accounted for 21% of notifications, with the remainder reported as either influenza A and B co-infections or untyped. Of the type A cases, 82% were not subtyped, 16% were reported as A(H1N1)pdm09 and 2% were A(H3N2). Approximately 40% of the notifications for this period were from Queensland (229).

Nationally, influenza activity levels are low and stable, but higher than at the same time in previous years. There is no indication that the 2014 influenza season has commenced, nor any indication of the potential severity of the season.

The Australian Government Department of Health continues to monitor influenza activity and will provide a fortnightly summary of influenza activity on the website. The fortnightly Australian Influenza Surveillance Report will commence closer to the onset of the winter influenza season.

Measles

There have been 11 cases notified in this reporting period including nine from Qld and one each from SA and Vic. This includes a cluster of seven cases currently under investigation in Qld.

Of the 210 cases notified year to date:

  • The majority were either imported from overseas 40% (n=85) or import related 32% (n=68) and associated with travel to the Philippines and Singapore.
  • Over a quarter of cases are currently reported as being acquired in Australia with the link to an imported case either unable to be established or currently under investigation.
  • Cases continue to be highest in the 15-19 and 30-34 years age groups, representing over a third of cases. Additionally, 9% of cases (n=18) are less than 12 months of age.
  • Of those cases aged over 12 months (n=192) and eligible for vaccination, 37% (n=77) were reported as not vaccinated and a further 35% (n=74) had an unknown vaccination status reported. The remaining 20% of cases (n=41) were reported as being vaccinated of which most (n=35) were partially vaccinated having received only one dose of a measles containing vaccine.
  • Vaccination is the best protection against measles. All travellers should ensure that they are up to date with routinely recommended vaccinations including measles prior to travel. More information is available on vaccination from the National Immunisation Programme.

top of page

Interpretative Notes

Selected diseases are chosen each fortnight based on either exceeding two standard deviations from the 90 day and/or 365 day five year rolling mean or other disease issues of significance identified during the reporting period. All diseases reported are analysed by notification receive date. Data are extracted each Monday of a CDNA week.

Totals comprise data from all States and Territories. Cumulative figures are subject to retrospective revision so there may be discrepancies between the number of new notifications and the increment in the cumulative figure from the previous period.

  1. The past quarter (90 day) surveillance period includes the date range 2 March 2014 to 30 May 2014.
  2. The quarterly (90 day) five year rolling mean is the average of 5 intervals of 90 days up to 30 May 2014. The ratio is the notification activity in the past quarter (90 days) compared with the five year rolling mean for the same period.
  3. The past year (365 day) surveillance period includes the date range 31 May 2013 to 30 May 2014.
  4. The yearly (365 day) five year rolling mean is the average of 5 intervals of 365 days up to 20 May 2014. The ratio is the notification activity in the past year (365 days) compared with the five year rolling mean for the same period.

The five year rolling mean and the ratio of notifications compared with the five year rolling mean should be interpreted with caution. Changes in surveillance practice, diagnostic techniques and reporting may contribute to increases or decreases in the total notifications received over a five year period. Ratios are to be taken as a crude measure of current disease activity and may reflect changes in reporting rather than changes in disease activity.

top of page

Table of communicable disease notifications reported to the NNDSS for this fortnight

Please use the scroll bar located at the end of the table below to view all columns.

A copy of the table of communicable disease notifications for this fortnight is also included in the PDF printable version of the NNDSS report.

Notifications of Nationally Notifiable Diseases for the period 17/05/2014 to 30/05/2014

Footnotes:

Ratio of the 90 day prior surveillance period to the past 90 day 5 year rolling mean, or ratio of the 365 day prior surveillance period to the 365 day 5 year rolling mean.

NN = Not Notifiable, NDP = No Data Provided, NEC = Not Elsewhere Classified

Dates used are:

  • Past Quarter (90d prior surveillance period): 02/03/2014 to 30/05/2014
  • Quarterly rolling 5Yr Mean (90d 5Yr Mean):
  • Quarterly rolling 5Yr Mean (90d 5Yr Mean) 1: 02/03/2013 to 30/05/2013
  • Quarterly rolling 5Yr Mean (90d 5Yr Mean) 2: 02/03/2012 to 30/05/2012
  • Quarterly rolling 5Yr Mean (90d 5Yr Mean) 3: 02/03/2011 to 30/05/2011
  • Quarterly rolling 5Yr Mean (90d 5Yr Mean) 4: 02/03/2010 to 30/05/2010
  • Quarterly rolling 5Yr Mean (90d 5Yr Mean) 5: 02/03/2009 to 30/05/2009
  • Past year (365d prior surveillance period): 31/05/2013 to 30/05/2014
  • Yearly rolling 5Yr Mean (365d 5Yr Mean):
  • Yearly rolling 5Yr Mean (365d 5Yr Mean) 1: 31/05/2012 to 30/05/2013
  • Yearly rolling 5Yr Mean (365d 5Yr Mean) 2: 01/06/2011 to 30/05/2012
  • Yearly rolling 5Yr Mean (365d 5Yr Mean) 3: 31/05/2010 to 30/05/2011
  • Yearly rolling 5Yr Mean (365d 5Yr Mean) 4: 31/05/2009 to 30/05/2010
  • Yearly rolling 5Yr Mean (365d 5Yr Mean) 5: 31/05/2008 to 30/05/2009
  State or Territory Totals for Australia Historical 90 Day Period Historical 365 Day Period
Disease ACT NSW NT QLD SA TAS VIC WA This
Reporting
Period		 Previous
Reporting
Period		 Same
Reporting
Period
Last Year		 2014 YTD Past
Quarter		 Quarterly
Rolling
5 year
mean		 Ratio
Past
Quarter
/5 year
mean		 Exceeds
Quarterly
rolling
mean +2
SD by		 Past
Year		 Yearly
rolling
5 year
mean		 Ratio
Past
year
/5 year
mean		 Exceeds
Yearly
rolling
mean +2
SD by;
Bloodborne diseases
Hepatitis (NEC) 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 - 0 0.0 0.0 -
Hepatitis B (newly acquired) 1 2 0 1 0 0 1 3 8 5 7 83 45 53.6 0.8 - 182 220.2 0.8 -
Hepatitis B (unspecified) 7 110 3 36 10 4 59 25 254 266 294 2,713 1,674 1,678.2 1.0 - 6,876 6,732.6 1.0 -
Hepatitis C (newly acquired) 1 2 0 0 1 0 3 2 9 19 11 177 90 108.2 0.8 - 404 415.8 1.0 -
Hepatitis C (unspecified) 7 127 9 137 10 13 58 34 395 456 409 4,201 2,591 2,567.4 1.0 - 10,392 10,421.4 1.0 -
Hepatitis D 0 1 0 0 0 0 0 0 1 4 5 16 10 10.0 1.0 - 50 37.2 1.3 -
Gastrointestinal diseases
Botulism 0 0 0 0 0 0 0 0 0 1 0 1 1 0.6 1.7 - 3 1.0 3.0 -
Campylobacteriosis 20 NN 10 256 69 31 169 113 668 773 495 7,766 4,460 3,596.2 1.2 190.6 16,698 16,147.6 1.0 -
Cryptosporidiosis 0 18 3 22 6 3 13 15 80 147 156 1,352 774 1,369.4 0.6 - 2,619 2,899.8 0.9 -
Haemolytic uraemic syndrome (HUS) 0 1 0 1 0 0 0 0 2 0 0 12 3 2.2 1.4 - 19 16.0 1.2 -
Hepatitis A 0 0 0 1 0 0 1 0 2 10 5 114 57 71.2 0.8 - 215 271.4 0.8 -
Hepatitis E 0 0 0 0 0 0 0 0 0 2 1 14 10 11.6 0.9 - 29 37.6 0.8 -
Listeriosis 0 1 0 0 1 0 1 0 3 4 3 36 21 22.6 0.9 - 69 79.6 0.9 -
STEC, VTEC 0 1 0 0 1 0 0 0 2 8 2 65 34 26.4 1.3 - 177 106.8 1.7 18.7
Salmonellosis 11 174 21 204 48 3 144 59 664 782 521 8,378 4,984 3,365.8 1.5 978.8 14,696 11,043.0 1.3 850.9
Shigellosis 0 1 3 13 1 0 21 2 41 27 12 495 249 138.0 1.8 57.7 799 580.2 1.4 -
Typhoid Fever 0 2 0 0 0 0 2 1 5 5 4 61 25 36.2 0.7 - 121 121.6 1.0 -
Quarantinable diseases
Cholera 0 0 0 0 0 0 0 1 1 0 0 2 2 1.8 1.1 - 5 4.6 1.1 -
HPAIH 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 - 0 0.0 0.0 -
Plague 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 - 0 0.0 0.0 -
Rabies 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 - 0 0.0 0.0 -
Severe Acute Respiratory Syndrome (SARS) 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 - 0 0.0 0.0 -
Smallpox 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 - 0 0.0 0.0 -
Viral haemorrhagic fever (NEC) 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 - 0 0.0 0.0 -
Yellow fever 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0.0 - 0 0.5 0.0 -
Sexually transmissible infections
Chlamydial infection 53 857 33 822 214 51 591 466 3,087 3,668 3,465 36,191 21,620 19,493.6 1.1 - 84,094 73,895.6 1.1 -
Donovanosis 0 0 0 0 0 0 0 0 0 0 0 1 1 0.0 0.0 - 1 1.0 1.0 -
Gonococcal infection 6 172 30 135 43 1 70 80 537 663 600 6,728 3,864 2,974.6 1.3 - 15,669 10,930.6 1.4 -
Syphilis - congenital 0 0 0 0 0 0 0 0 0 0 0 1 1 1.4 0.7 - 6 4.0 1.5 -
Syphilis < 2 years 1 3 0 13 0 2 14 6 39 52 54 678 381 353.8 1.1 - 1,733 1,349.2 1.3 15.6
Syphilis > 2 years or unspecified duration 2 4 0 7 2 0 32 2 49 82 70 709 423 367.0 1.2 - 1,713 1,381.6 1.2 161.2
Vaccine preventable diseases
Diphtheria 0 0 0 0 0 0 0 0 0 0 0 0 0 1.0 0.0 - 1 1.0 1.0 -
Haemophilus influenzae type b 0 0 0 1 0 0 0 0 1 1 1 6 4 3.8 1.1 - 20 18.0 1.1 -
Influenza (laboratory confirmed) 6 79 6 229 50 9 133 70 582 579 385 6,171 3,536 2,089.4 1.7 939.6 30,684 31,296.6 1.0 -
Measles 0 0 0 9 1 0 1 0 11 5 4 210 79 31.0 2.5 - 344 119.0 2.9 111.5
Mumps 0 2 0 4 0 0 2 2 10 3 13 93 49 48.2 1.0 - 201 167.4 1.2 -
Pertussis 10 63 1 52 8 3 125 54 316 337 407 3,714 1,976 5,876.8 0.3 - 10,639 28,976.8 0.4 -
Pneumococcal disease (invasive) 0 17 1 12 4 1 18 7 60 55 73 426 295 317.8 0.9 - 1,522 1,712.6 0.9 -
Poliomyelitis 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 - 0 0.0 0.0 -
Rubella 0 1 0 0 0 0 0 0 1 0 2 8 2 11.6 0.2 - 29 38.8 0.7 -
Rubella Congenital 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0.0 - 1 0.4 2.5 -
Tetanus 0 0 0 0 0 0 0 0 0 0 0 1 1 1.0 1.0 - 1 3.8 0.3 -
Varicella zoster (Chickenpox)+ 0 NN 0 0 11 1 6 13 31 70 70 727 429 373.2 1.1 - 2,135 1,924.6 1.1 -
Varicella zoster (Shingles)+ 2 NN 7 1 43 1 3 30 87 204 203 2,116 1,164 930.4 1.3 - 5,024 3,561.6 1.4 -
Varicella zoster (Unspecified)+ 10 NN 0 222 42 12 21 47 354 426 350 4,526 2,649 1,870.4 1.4 347.9 10,703 7,325.2 1.5 949.5
Vectorborne diseases
Arbovirus infection (NEC) 0 1 0 1 0 0 0 0 2 2 1 23 21 2.2 9.5 16.2 37 11.8 3.1 14.1
Barmah Forest virus infection 0 2 0 20 0 0 0 0 22 40 245 495 230 748.2 0.3 - 2,254 1,990.2 1.1 -
Dengue virus infection 1 14 2 21 6 1 0 19 64 70 84 932 451 391.4 1.2 - 1,920 1,231.0 1.6 -
Japanese encephalitis virus infection 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 - 4 0.4 10.0 2.5
Kunjin virus infection 0 0 0 0 0 0 0 0 0 0 0 2 1 0.6 1.7 - 4 1.4 2.9 0.3
Malaria 0 5 0 4 0 0 0 2 11 11 11 134 70 80.6 0.9 - 359 439.2 0.8 -
Murray Valley encephalitis virus infection 0 0 0 0 0 0 0 0 0 0 0 0 0 3.6 0.0 - 1 4.2 0.2 -
Ross River virus infection 1 34 16 120 3 0 0 38 212 256 198 2,619 1,677 1,997.8 0.8 - 4,554 4,797.8 0.9 -
Zoonoses
Anthrax 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 - 0 0.2 0.0 -
Australian bat lyssavirus 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 - 0 0.2 0.0 -
Brucellosis 0 0 0 1 0 0 0 0 1 0 3 8 2 6.4 0.3 - 18 31.8 0.6 -
Leptospirosis 0 0 0 1 0 0 0 1 2 6 6 45 27 52.6 0.5 - 97 138.0 0.7 -
Lyssavirus (NEC) 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 - 0 0.0 0.0 -
Ornithosis 0 0 0 0 0 0 0 0 0 1 2 11 8 12.4 0.6 - 46 75.0 0.6 -
Q fever 0 1 0 12 0 0 0 0 13 17 21 213 102 95.0 1.1 - 492 352.0 1.4 77.9
Tularaemia 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0.0 - 0 0.5 0.0 -
Other bacterial infections
Legionellosis 1 0 0 3 1 0 5 4 14 23 7 165 110 90.0 1.2 11.4 522 330.0 1.6 119.3
Leprosy 0 0 0 0 0 0 0 0 0 1 1 6 3 1.8 1.7 - 14 8.4 1.7 1.7
Meningococcal disease (invasive) 0 0 0 2 1 0 1 1 5 4 3 49 33 45.2 0.7 - 142 243.0 0.6 -
Tuberculosis 0 5 0 2 1 0 14 6 28 49 36 494 283 287.4 1.0 - 1,240 1,325.0 0.9 -
Totals 140 1,700 145 2,365 577 136 1,508 1,103 7,674 9,134 8,240 92,988 54,522        229,578       

top of page


Related Links

In this section

Communicable Diseases Surveillance